HTI’s mission is to expand patient and consultant access to technologies and services which will improve the clinical outcome for cancer patients. Proton therapy has clinically proven to provide positive results for cancer patients with certain site specific types of cancer. The increased cost justification for certain cancer types may vary from country to country but virtually all countries now recognize that proton therapy offers enhanced clinical benefits for many types of cancers.

HTI working in partnership with our proton partners is dedicated to expanding regional access to proton therapy and in the interim to providing a seamless referral network for those patients and families seeking access to proton therapy until such time as their regional service is available.